Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Biopharmaceutics & Drug Disposition|January 22, 2009
Pharmacodynamics of glucose regulation by methylprednisolone. II. normal ratsJin Y Jin, William J Jusko
Biopharmaceutics & Drug Disposition|January 22, 2009
Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized ratsJin Y Jin, William J Jusko
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 13, 2023
The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and developmentAmita Joshi, Saroja Ramanujan, Jin Y Jin
CPT: Pharmacometrics & Systems Pharmacology|July 2, 2025
Shap-Cov: An Explainable Machine Learning Based Workflow for Rapid Covariate Identification in Population ModelingLogan Brooks, Rashed Harun, Jin Y Jin, et al.
Nature Machine Intelligence|April 24, 2025
Deep learning prediction of patient response time course from early data via neural-pharmacokinetic/pharmacodynamic modellingJames Lu, Brendan Bender, Jin Y Jin, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 27, 2019
Analysis of Longitudinal-Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric ModelsTong Lu, Yujie Yang, Jin Y Jin, et al.
Journal of Pharmaceutical Sciences|October 3, 2009
Absorption barriers in the rat intestinal mucosa: 2. Application of physiologically based mathematical models to quantify mechanisms of drug permeation and metabolismDaniel R Mudra, Jin Y Jin, Ronald T Borchardt
Cancer Chemotherapy and Pharmacology|June 27, 2024
Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancerAnita Moein, Jin Y Jin, Matthew R Wright, et al.
Journal of Clinical Pharmacology|April 19, 2024
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure-Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor)Anita Moein, Jin Y Jin, Matthew R Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liverJin Y Jin, Debra C DuBois, Richard R Almon, et al.
Pageof 7